Fumino Tokito

Title: Fumino Tokito: Innovator in Gene Therapy

Fumino Tokito is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of gene therapy through his innovative research and patents. His work focuses on the development of viral vectors that can be utilized in therapeutic applications.

Latest Patents

Fumino Tokito holds a patent for an envelope gene-deficient Paramyxovirus vector. This patent details the successful recovery of F gene-deficient virus virions using an F gene-deficient Sendai virus genomic cDNA. Additionally, he has constructed F gene-deficient infectious viral particles by employing F-expressing cells as helper cells. His research also includes the recovery of F gene and HN gene-deficient virus virions, as well as the production of infectious viral particles using F- and HN-expressing cells. Furthermore, he has developed a virus deficient in both F gene and HN gene, which incorporates F protein through the use of F-expressing cells. His work extends to the production of M gene-deficient infectious virus particles and the construction of a VSV-G pseudo type virus using VSV-G-expressing cells. These techniques are pivotal for advancing the development of Paramyxoviridae vectors for gene therapy.

Career Highlights

Fumino Tokito is associated with Dna Vec Research Inc., where he continues to push the boundaries of gene therapy research. His innovative approaches and findings have positioned him as a key figure in the field.

Collaborations

Fumino collaborates with notable colleagues, including Kaio Kitazato and Tsugumine Shu, who contribute to his research endeavors.

Conclusion

Fumino Tokito's work in developing gene-deficient viral vectors represents a significant advancement in gene therapy. His innovative research continues to pave the way for new therapeutic possibilities.